About
Lisa Ricciardi is a life sciences executive and the President & Chief Executive Officer of Cognition Therapeutics, where she joined the board in March 2019 and became acting CEO in March 2020 before leading the company through its IPO. Her background spans biotech operating leadership, drug commercialization, and business development roles at Suono Bio, Foundation Medicine, Express Scripts, Pfizer, and Essex Woodlands Health Ventures. Her current work is centered on neurodegenerative disease therapeutics, especially Alzheimer's disease and dementia with Lewy bodies.
Areas of interest
biotechneuroscienceneurodegenerationAlzheimer's diseasedementia with Lewy bodiesaging researchdrug developmentdrug commercializationgenomicshealthcare business developmentcapital raising